The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 10, 2012, Pages 1659-1666

  Wang, Bing ^a   Zhang, Qingyun ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Cancers; MiR 21; Real time PCR; Serum; Serum based biomarker

Indexed keywords

MICRORNA 21; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BREAST CANCER; CANCER PATIENT; CANCER STAGING; CHINA; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; GENE OVEREXPRESSION; HUMAN; LUNG CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; STOMACH CANCER;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84866679008     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1244-9     Document Type: Article

References (38)

1. Asaga S, Kuo C, Nguyen T, Terpenning M, Giuliaono AE, Hoon DSB (2011) Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin Chem 57(1):84-91
2. Asangani A, Rasheed SAK, Nikolova DA, Leupold JH, Colburn NH, Post S, Allgayer H (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27:2128-2136
3. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281-297
4. Brase JC, Wuttig D, Kuner R, Sültmann H (2010) Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer 9:306
5. Brown BD, Naldini L (2009) Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Nat Rev Genet 10:578-585
6. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101(9):2999-3004
7. Chen X, Ba Y, Ma LJ, Cai X, Yin Y, Wang KH, Guo JG, Zhang YJ, Chen JN, Guo X, Li QB, Li XY, Wang WJ, Zhang Y, Wang J, Jiang XY, Xiang Y, Xu C, Zheng PP, Zhang JB, Li RQ, Zhang HJ, Shang XB, Gong T, Ning G, Wang J, Zen K, Zhang JF, Zhang CY (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18(10):997-1006
8. Duffy MJ (2001) Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 38(3):225-262
9. Duffy MJ (2007) Role of tumor markers in patients with solid cancers: a critical review. Eur J Intern Med 18(3):175-184
10. Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471-1474
11. Esquela-Kerscher A, Slack FJ (2006) Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6(4):259-269
12. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ (2006) MiRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34:D140-D144
13. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, Kerin MJ (2010) Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 251(3):499-505
14. Hu ZB, Chen X, Zhao Y, Tian T, Jin GF, Shu YQ, Chen YJ, Xu L, Zen K, Zhang CY, Shen HB (2010) Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 28(10):1721-1726
15. Huang ZH, Huang D, Ni SJ, Peng ZL, Sheng WQ, Du X (2010) Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127(1):118-126
16. Jemal A, Freddie B, Melissa MC, Jacques F, Elizabeth W, David F (2011) Global cancer statistics. CA Cancer J Clin 61(2):69-90
17. Kosaka N, Iguchi H, Ochiya T (2010) Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 101(10):2087-2092
18. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J, Wainscoat JS, Hatton CSR, Harris AL (2008) Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 141(5):672-675
19. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120(1):15-20
20. Liu CJ, Kao SY, Tu HF, Tsai MM, Chang KW, Lin SC (2010) Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. Oral Dis 16(4):360-364
21. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4):402-408
22. Love TM, Moffett HF, Novina CD (2008) Not miR-ly small RNAs: big potential for microRNAs in therapy. J Allergy Clin Immunol 121(2):309-319
23. Meng FY, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterol-ogy 133(2):647-658
24. Roulston JE (1990) Limitations of tumour markers in screening. Br J Surg 77(9):961-962
25. Schmittgen TD, Jiang JM, Liu Q, Yang LQ (2004) A high-throughput method to monitor the expression of microRNA precursors. Nucleic Acids Res 32(4):e43
26. Shen J, Todd NW, Zhang H, Yu L, Lingxiao X, Mei YP, Guarnera M, Liao JP, Chou A, Lu CL, Jiang ZR, Fang HB, Katz RL, Jiang F (2011) Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab Invest 91(4):579-587
27. Song JN, Bai ZG, Han W, Zhang J, Meng H, Bi JT, Ma XM, Han SW, Zhang ZT (2011) Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients. Dig Dis Sci 57(4):897-904
28. Thomas CMG, Sweep CGJ (2001) Serum tumor markers: past, state of the art, and future. Int J Biol Markers 16(2):73-86
29. Wang J, Chen J, Chang P, LeBlanc A, Li DH, Abbruzzesse JL, Frazier ML, Killary AM, Sen S (2009) MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res (Phila Pa) 2(9):807-813
30. Wang F, Zheng Z, Guo J, Ding X (2010) Correlation and quantitation of micrRNA aberrant expression in tissue and sera from patients with breast tumor. Gynecol Oncol 119(3):586-593
31. Wong TS, Liu XB, Wong BYH, Ng RWM, Yuen APW, Wei WL (2008) Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Rse 14(9): 2588-2592
32. Xiao JJ, Jing ZC, Ellinor PT, Liang DD, Zhang H, Liu Y, Chen XL, Pan L, Lyon R, Liu Y, Peng LY, Liang XQ, Sun YF, Popescu LM, Condorelli G, Chen YH (2011) MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism. J Transl Med 9:159
33. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14(11): 2348-2360
34. Zamore PD, Haley B (2005) Ribo-gnome: the big world of small RNAs. Science 309(5740):1519-1524
35. Zhang ZY, Li ZJ, Gao CP, Chen P, Chen JJ, Liu WZ, Xiao SD, Lu H (2008) miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 88(12):1358-1366
36. Zheng DL, Haddadin S, Wang Y, Gu LQ, Perry MC, Freter CE, Wang MX (2011) Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int J Clin Exp Pathol 4(6):575-586
37. Zhu SM, Si M-L, Wu H, Mo YY (2007) MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282(19):14328-14336
38. Zhu SM, Wu HL, Wu FT, Nie DT, Sheng SJ, Mo YY (2008) MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 18(3):350-359